Express Scripts (ESRX) 87.34 $ESRX
Rite Aid’s Incredible Turnaround: Beyond the Numbers
Kristine Harjes and Michael Douglass, The Motley Fool - Motley Fool - Sat Apr 25, 8:01AM CDT
We've all seen the retail pharmacies -- more than a few of them, for sure. They're on every corner, some of which even share adjoining properties. With health care needs on the rise, and all the reforms to insurance, retail pharmacies are trying to...
T: 34.01 (-0.22), ESRX: 87.34 (+0.45), WBA: 85.98 (-0.71), MCK: 229.20 (+0.09), AXP: 77.99 (-0.16), UNH: 118.69 (+0.43), XOM: 86.97 (-0.57), WMT: 79.84 (+0.66), M: 66.99 (-0.43), CVS: 101.58 (+0.70), RAD: 8.25 (-0.01)
5 Things UnitedHealth Wants You to Know
Cheryl Swanson, The Motley Fool - Motley Fool - Thu Apr 23, 8:08AM CDT
UnitedHealth 's latest earnings were so stellar that CEO Stephen Hemsley put on his happy face during the health insurer's recent earnings call. In fact, UnitedHealth's usually dour and terse CEO was so consistently upbeat he used the word "growth"...
HCA: 77.74 (+0.30), ESRX: 87.34 (+0.45), CTRX: 59.56 (+0.05), GILD: 103.69 (-1.52), UNH: 118.69 (+0.43), JCP: 8.41 (-0.07), CVS: 101.58 (+0.70), ABBV: 66.07 (+1.82)
Forget Gilead (GILD), Buy These Impressive Biotech Stocks Instead - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 8:09AM CDT
It's time we overlooked Gilead for some biotech growth stocks.
BIIB: 401.71 (-28.57), JNJ: 101.08 (+0.62), ESRX: 87.34 (+0.45), PCYC: 256.59 (-0.51), GILD: 103.69 (-1.52), ANTH: 5.20 (+0.31), GERN: 4.30 (-0.03), ABBV: 66.07 (+1.82)
Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs
PR Newswire - Tue Apr 21, 7:30AM CDT
Workers' compensation pharmacy spending increased 1.9 percent in 2014, as a 5.4 percent decrease in utilization helped offset a 7 percent increase in the cost per prescription, according to new data released today by Express Scripts (NASDAQ: ESRX).
ESRX: 87.34 (+0.45)
UnitedHealth's Earnings Deliver, but Risks Lurk Beneath the Surface
Cheryl Swanson, The Motley Fool - Motley Fool - Mon Apr 20, 9:08PM CDT
Investors hoping for strong first-quarter numbers from the nation's largest insurer got what they were looking for last Friday. UnitedHealth Group Inc . topped forecasts, with revenue and earnings per share up 13% ...
CI: 130.66 (+0.09), HCA: 77.74 (+0.30), ESRX: 87.34 (+0.45), CTRX: 59.56 (+0.05), UNH: 118.69 (+0.43)
Double-Digit Spike in Drug Costs Prescribes Profits for PBMs
Bruce Japsen, The Motley Fool - Motley Fool - Mon Apr 20, 8:21AM CDT
The spike in employer spending on prescription drugs is now forecast to jump around 10% for the next three years, according to a new report that puts pressure on companies to dramatically alter pharmacy benefits. And while that's bad news for...
ESRX: 87.34 (+0.45), CTRX: 59.56 (+0.05), GILD: 103.69 (-1.52), UNH: 118.69 (+0.43), CVS: 101.58 (+0.70), AON: 97.84 (+0.43), ABBV: 66.07 (+1.82)
What Could Possibly Go Wrong With Gilead Sciences Inc. Stock?
Keith Speights, The Motley Fool - Motley Fool - Sat Apr 18, 9:02AM CDT
Source: Wikimedia Commons . Chip and Dan Heath give valuable advice on making decisions in their book "Decisive: How to Make Better Choices in Life and Work". In the book, the Heath brothers recommend taking four actions to make better decisions:...
ESRX: 87.34 (+0.45), GILD: 103.69 (-1.52), MRK: 57.60 (+0.09), ABBV: 66.07 (+1.82)
AbbVie's HCV Treatment Granted Priority Review in Japan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 16, 5:14PM CDT
AbbVie's (ABBV) its experimental HCV treatment was granted priority review in Japan.
BIIB: 401.71 (-28.57), ESRX: 87.34 (+0.45), GILD: 103.69 (-1.52), ABBV: 66.07 (+1.82)
Why CVS Health And McKesson May Be Good Stock Picks
at Investor's Business Daily - Thu Apr 16, 4:54PM CDT
As March data pointed to a strong month for prescription drugs sold in the U.S., two stocks in the supply chain were singled out Thursday as "top ideas." In a drug supply-chain report, Evercore ISI singled out CVS Health (CVS) and drug-distribution...
ESRX: 87.34 (+0.45), MCK: 229.20 (+0.09), CAH: 91.38 (-0.12), CVS: 101.58 (+0.70), AET: 108.82 (-0.08)
UnitedHealth Up After Topping Views, Raising Outlook
at Investor's Business Daily - Thu Apr 16, 8:24AM CDT
Shares of UnitedHealth Group (UNH) moved higher Thursday after the nation's biggest health insurer topped first-quarter earnings and revenue views and raised its 2015 forecast, boosted by another strong performance from its Optum Health Services...
CI: 130.66 (+0.09), ANTM: 154.28 (+0.08), HCA: 77.74 (+0.30), ESRX: 87.34 (+0.45), CTRX: 59.56 (+0.05), UNH: 118.69 (+0.43), CVS: 101.58 (+0.70), AET: 108.82 (-0.08), HUM: 182.35 (+0.44)
The Best Stock to Invest in Hep C
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 16, 7:03AM CDT
Source: Gilead Sciences. The market for hepatitis C treatment is among the most lucrative for drugmakers, but it's also one of the most dynamically changing markets. Only 10 years ago, patients were treated with side effect-laden cocktails of drugs...
JNJ: 101.08 (+0.62), ESRX: 87.34 (+0.45), GILD: 103.69 (-1.52), ACHN: 10.06 (+0.06), MRK: 57.60 (+0.09), RGLS: 17.49 (-0.80), ABBV: 66.07 (+1.82), BMY: 65.80 (-0.20)
Express Scripts Set to Possibly Rebound After Yesterday's Selloff of 1.14%
Comtex SmarTrend(R) - Wed Apr 15, 4:21PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $86.37 to a high of $88.57. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $87.79 on volume of 4.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ESRX: 87.34 (+0.45)
SmarTrend Watching for Potential Rebound in Shares of Express Scripts After 1.14% Loss
Comtex SmarTrend(R) - Wed Apr 15, 4:20PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $86.37 to a high of $88.57. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $87.79 on volume of 4.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ESRX: 87.34 (+0.45)
3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 9:52AM CDT
The biotech sector is witnessing changing dynamics with the focus shifting from large caps to smaller companies with high growth potential.
JNJ: 101.08 (+0.62), ESRX: 87.34 (+0.45), PCYC: 256.59 (-0.51), GILD: 103.69 (-1.52), ANTH: 5.20 (+0.31), CYTX: 0.99 (+0.01), GERN: 4.30 (-0.03), PFE: 35.27 (-0.09), AMGN: 167.91 (-1.26), ABBV: 66.07 (+1.82), HSP: 87.61 (-0.05), NVS: 104.28 (-1.22)
UnitedHealth Eyes Biggest Earnings Gain In Years
at Investor's Business Daily - Mon Apr 13, 7:02AM CDT
UnitedHealth Group (UNH) is expected to produce its best performance in years when it reports first-quarter results Thursday, while its stock price continues to trade near record highs following a major acquisition at the end of March. Analysts...
CI: 130.66 (+0.09), ANTM: 154.28 (+0.08), ESRX: 87.34 (+0.45), CTRX: 59.56 (+0.05), UNH: 118.69 (+0.43), CVS: 101.58 (+0.70), AET: 108.82 (-0.08), HUM: 182.35 (+0.44)
The Long Strange Trip Of Walgreens And Express Scripts
Dana Blankenhorn - at Seeking Alpha - Sat Apr 11, 9:57AM CDT
ESRX: 87.34 (+0.45), CTRX: 59.56 (+0.05), WBA: 85.98 (-0.71), UNH: 118.69 (+0.43), CVS: 101.58 (+0.70)
A New Drug Could Halt Weight Gain in Patients Taking These Antipsychotics
Todd Campbell, The Motley Fool - Motley Fool - Sat Apr 11, 9:14AM CDT
Source: Alkermes Plc Alkermes Plc is developing a new antipsychotic drug that could remove a major side effect that is associated with atypical antipsychotic medicines, including Eli Lilly and Co. 's Zyprexa. Atypical antipsychotics are...
ESRX: 87.34 (+0.45), LLY: 71.58 (-0.82), ALKS: 62.26 (-1.19)
Don't Play On Takeover Rumors - Cramer's Mad Money (4/9/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Fri Apr 10, 6:47AM CDT
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, April 9. Sometimes, the market gets the correlations wrong. As the dollar got stronger yesterday, everyone thought this would mean weaker oil, which made every...
ACT: 295.41 (-2.95), PRGO: 192.89 (-8.74), TERP: 41.68 (-0.38), SPG: 188.71 (-0.35), BRCM: 44.46 (-0.98), ALTR: 40.89 (-1.20), MYL: 76.06 (+2.37), STZ: 115.64 (-0.36), AGN: 240.22 (+2.88), ESRX: 87.34 (+0.45), WBA: 85.98 (-0.71), NVAX: 8.58 (-0.07), SUNE: 26.61 (-0.89), HZNP: 31.75 (+0.97), COST: 148.12 (+0.82), AAL: 52.71 (+1.26), TEVA: 64.41 (+1.16), MAC: 83.23 (+0.89), TWTR: 50.82 (-0.59)
Express Scripts Rises 4.87% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Apr 09, 3:51PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $84.82 to a high of $89.25. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $85.39 on volume of 8.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 87.34 (+0.45)
Look for Shares of Express Scripts to Potentially Pullback after Yesterday's 4.87% Rise
Comtex SmarTrend(R) - Thu Apr 09, 3:51PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $84.82 to a high of $89.25. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $85.39 on volume of 8.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 87.34 (+0.45)
Rite Aid’s Incredible Turnaround: Beyond the Numbers
Kristine Harjes and Michael Douglass, The Motley Fool - Motley Fool - Sat Apr 25, 8:01AM CDT
We've all seen the retail pharmacies -- more than a few of them, for sure. They're on every corner, some of which even share adjoining properties. With health care needs on the rise, and all the reforms to insurance, retail pharmacies are trying to...
T: 34.01 (-0.22), ESRX: 87.34 (+0.45), WBA: 85.98 (-0.71), MCK: 229.20 (+0.09), AXP: 77.99 (-0.16), UNH: 118.69 (+0.43), XOM: 86.97 (-0.57), WMT: 79.84 (+0.66), M: 66.99 (-0.43), CVS: 101.58 (+0.70), RAD: 8.25 (-0.01)
5 Things UnitedHealth Wants You to Know
Cheryl Swanson, The Motley Fool - Motley Fool - Thu Apr 23, 8:08AM CDT
UnitedHealth 's latest earnings were so stellar that CEO Stephen Hemsley put on his happy face during the health insurer's recent earnings call. In fact, UnitedHealth's usually dour and terse CEO was so consistently upbeat he used the word "growth"...
HCA: 77.74 (+0.30), ESRX: 87.34 (+0.45), CTRX: 59.56 (+0.05), GILD: 103.69 (-1.52), UNH: 118.69 (+0.43), JCP: 8.41 (-0.07), CVS: 101.58 (+0.70), ABBV: 66.07 (+1.82)
Forget Gilead (GILD), Buy These Impressive Biotech Stocks Instead - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 8:09AM CDT
It's time we overlooked Gilead for some biotech growth stocks.
BIIB: 401.71 (-28.57), JNJ: 101.08 (+0.62), ESRX: 87.34 (+0.45), PCYC: 256.59 (-0.51), GILD: 103.69 (-1.52), ANTH: 5.20 (+0.31), GERN: 4.30 (-0.03), ABBV: 66.07 (+1.82)
Workers' Compensation Prescription Drug Spend Increased 1.9 Percent in 2014, Stabilized by Effective Utilization Management Programs
PR Newswire - Tue Apr 21, 7:30AM CDT
Workers' compensation pharmacy spending increased 1.9 percent in 2014, as a 5.4 percent decrease in utilization helped offset a 7 percent increase in the cost per prescription, according to new data released today by Express Scripts (NASDAQ: ESRX).
ESRX: 87.34 (+0.45)
UnitedHealth's Earnings Deliver, but Risks Lurk Beneath the Surface
Cheryl Swanson, The Motley Fool - Motley Fool - Mon Apr 20, 9:08PM CDT
Investors hoping for strong first-quarter numbers from the nation's largest insurer got what they were looking for last Friday. UnitedHealth Group Inc . topped forecasts, with revenue and earnings per share up 13% ...
CI: 130.66 (+0.09), HCA: 77.74 (+0.30), ESRX: 87.34 (+0.45), CTRX: 59.56 (+0.05), UNH: 118.69 (+0.43)
Double-Digit Spike in Drug Costs Prescribes Profits for PBMs
Bruce Japsen, The Motley Fool - Motley Fool - Mon Apr 20, 8:21AM CDT
The spike in employer spending on prescription drugs is now forecast to jump around 10% for the next three years, according to a new report that puts pressure on companies to dramatically alter pharmacy benefits. And while that's bad news for...
ESRX: 87.34 (+0.45), CTRX: 59.56 (+0.05), GILD: 103.69 (-1.52), UNH: 118.69 (+0.43), CVS: 101.58 (+0.70), AON: 97.84 (+0.43), ABBV: 66.07 (+1.82)
What Could Possibly Go Wrong With Gilead Sciences Inc. Stock?
Keith Speights, The Motley Fool - Motley Fool - Sat Apr 18, 9:02AM CDT
Source: Wikimedia Commons . Chip and Dan Heath give valuable advice on making decisions in their book "Decisive: How to Make Better Choices in Life and Work". In the book, the Heath brothers recommend taking four actions to make better decisions:...
ESRX: 87.34 (+0.45), GILD: 103.69 (-1.52), MRK: 57.60 (+0.09), ABBV: 66.07 (+1.82)
AbbVie's HCV Treatment Granted Priority Review in Japan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 16, 5:14PM CDT
AbbVie's (ABBV) its experimental HCV treatment was granted priority review in Japan.
BIIB: 401.71 (-28.57), ESRX: 87.34 (+0.45), GILD: 103.69 (-1.52), ABBV: 66.07 (+1.82)
Why CVS Health And McKesson May Be Good Stock Picks
at Investor's Business Daily - Thu Apr 16, 4:54PM CDT
As March data pointed to a strong month for prescription drugs sold in the U.S., two stocks in the supply chain were singled out Thursday as "top ideas." In a drug supply-chain report, Evercore ISI singled out CVS Health (CVS) and drug-distribution...
ESRX: 87.34 (+0.45), MCK: 229.20 (+0.09), CAH: 91.38 (-0.12), CVS: 101.58 (+0.70), AET: 108.82 (-0.08)
UnitedHealth Up After Topping Views, Raising Outlook
at Investor's Business Daily - Thu Apr 16, 8:24AM CDT
Shares of UnitedHealth Group (UNH) moved higher Thursday after the nation's biggest health insurer topped first-quarter earnings and revenue views and raised its 2015 forecast, boosted by another strong performance from its Optum Health Services...
CI: 130.66 (+0.09), ANTM: 154.28 (+0.08), HCA: 77.74 (+0.30), ESRX: 87.34 (+0.45), CTRX: 59.56 (+0.05), UNH: 118.69 (+0.43), CVS: 101.58 (+0.70), AET: 108.82 (-0.08), HUM: 182.35 (+0.44)
The Best Stock to Invest in Hep C
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 16, 7:03AM CDT
Source: Gilead Sciences. The market for hepatitis C treatment is among the most lucrative for drugmakers, but it's also one of the most dynamically changing markets. Only 10 years ago, patients were treated with side effect-laden cocktails of drugs...
JNJ: 101.08 (+0.62), ESRX: 87.34 (+0.45), GILD: 103.69 (-1.52), ACHN: 10.06 (+0.06), MRK: 57.60 (+0.09), RGLS: 17.49 (-0.80), ABBV: 66.07 (+1.82), BMY: 65.80 (-0.20)
Express Scripts Set to Possibly Rebound After Yesterday's Selloff of 1.14%
Comtex SmarTrend(R) - Wed Apr 15, 4:21PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $86.37 to a high of $88.57. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $87.79 on volume of 4.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ESRX: 87.34 (+0.45)
SmarTrend Watching for Potential Rebound in Shares of Express Scripts After 1.14% Loss
Comtex SmarTrend(R) - Wed Apr 15, 4:20PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $86.37 to a high of $88.57. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $87.79 on volume of 4.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ESRX: 87.34 (+0.45)
3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 9:52AM CDT
The biotech sector is witnessing changing dynamics with the focus shifting from large caps to smaller companies with high growth potential.
JNJ: 101.08 (+0.62), ESRX: 87.34 (+0.45), PCYC: 256.59 (-0.51), GILD: 103.69 (-1.52), ANTH: 5.20 (+0.31), CYTX: 0.99 (+0.01), GERN: 4.30 (-0.03), PFE: 35.27 (-0.09), AMGN: 167.91 (-1.26), ABBV: 66.07 (+1.82), HSP: 87.61 (-0.05), NVS: 104.28 (-1.22)
UnitedHealth Eyes Biggest Earnings Gain In Years
at Investor's Business Daily - Mon Apr 13, 7:02AM CDT
UnitedHealth Group (UNH) is expected to produce its best performance in years when it reports first-quarter results Thursday, while its stock price continues to trade near record highs following a major acquisition at the end of March. Analysts...
CI: 130.66 (+0.09), ANTM: 154.28 (+0.08), ESRX: 87.34 (+0.45), CTRX: 59.56 (+0.05), UNH: 118.69 (+0.43), CVS: 101.58 (+0.70), AET: 108.82 (-0.08), HUM: 182.35 (+0.44)
The Long Strange Trip Of Walgreens And Express Scripts
Dana Blankenhorn - at Seeking Alpha - Sat Apr 11, 9:57AM CDT
ESRX: 87.34 (+0.45), CTRX: 59.56 (+0.05), WBA: 85.98 (-0.71), UNH: 118.69 (+0.43), CVS: 101.58 (+0.70)
A New Drug Could Halt Weight Gain in Patients Taking These Antipsychotics
Todd Campbell, The Motley Fool - Motley Fool - Sat Apr 11, 9:14AM CDT
Source: Alkermes Plc Alkermes Plc is developing a new antipsychotic drug that could remove a major side effect that is associated with atypical antipsychotic medicines, including Eli Lilly and Co. 's Zyprexa. Atypical antipsychotics are...
ESRX: 87.34 (+0.45), LLY: 71.58 (-0.82), ALKS: 62.26 (-1.19)
Don't Play On Takeover Rumors - Cramer's Mad Money (4/9/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Fri Apr 10, 6:47AM CDT
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, April 9. Sometimes, the market gets the correlations wrong. As the dollar got stronger yesterday, everyone thought this would mean weaker oil, which made every...
ACT: 295.41 (-2.95), PRGO: 192.89 (-8.74), TERP: 41.68 (-0.38), SPG: 188.71 (-0.35), BRCM: 44.46 (-0.98), ALTR: 40.89 (-1.20), MYL: 76.06 (+2.37), STZ: 115.64 (-0.36), AGN: 240.22 (+2.88), ESRX: 87.34 (+0.45), WBA: 85.98 (-0.71), NVAX: 8.58 (-0.07), SUNE: 26.61 (-0.89), HZNP: 31.75 (+0.97), COST: 148.12 (+0.82), AAL: 52.71 (+1.26), TEVA: 64.41 (+1.16), MAC: 83.23 (+0.89), TWTR: 50.82 (-0.59)
Express Scripts Rises 4.87% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Apr 09, 3:51PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $84.82 to a high of $89.25. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $85.39 on volume of 8.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 87.34 (+0.45)
Look for Shares of Express Scripts to Potentially Pullback after Yesterday's 4.87% Rise
Comtex SmarTrend(R) - Thu Apr 09, 3:51PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $84.82 to a high of $89.25. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $85.39 on volume of 8.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 87.34 (+0.45)
